证券代码：000423 证券简称：东阿阿胶 公告编号：2026-06 东阿阿胶股份有限公司 关于投资建设健康消费品产业园项目的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、投资概述 为扎实落地东阿阿胶股份有限公司（以下简称"公司"或"东阿阿胶"）"1238" 发展战略，有效支撑健康消费品业务高质量发展，公司于 2026 年 2 月 9 日召开 第十一届董事会第十七次会议，审议通过了《关于投资建设健康消费品产业园项 目的议案》。 公司拟以 14.85 亿元（其中固定资产投资 14.21 亿元，铺底流动资金 0.64 亿元）的自有资金投资建设健康消费品产业园项目，用于药食同源食品、保健品、 功能性食品等健康消费品的生产与配套仓储物流、质检中心、新品孵化中心、电 商分拣及药品成品仓储等。公司董事会决议授权管理层具体推进落实该项目，包 括但不限于进一步完善规划设计、细化投资测算、建设施工，以及办理其他与本 投资事项相关的一切事宜。 1．项目名称：东阿阿胶健康消费品产业园建设项目 2．投资主体：东阿阿胶股份有限公司 3．建设地址：山东省聊城市东阿县经济开发区 ...

证券代码：000423 证券简称：东阿阿胶 公告编号：2026-05 1．东阿阿胶股份有限公司（以下简称"公司"）第十一届董事会第十七次 会议，于 2026 年 2 月 6 日以邮件方式发出会议通知。 2．本次董事会会议，于 2026 年 2 月 9 日以通讯表决方式召开。 3．会议应出席会议董事 9 人，实际出席会议董事 9 人。 第十一届董事会第十七次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 东阿阿胶股份有限公司 4．本次董事会会议的召开，符合有关法律、行政法规、部门规章、规范性 文件和公司章程等规定。 二、董事会会议审议情况 本次会议审议并通过了以下议案： 1．《关于调整董事会专门委员会委员的议案》 会议同意对公司第十一届董事会战略委员会、提名委员会、审计委员会及 薪酬与考核委员会组成人员进行补充调整，调整后的委员会成员名单如下： （1）董事会战略委员会 程杰（主任委员）、果德安、徐培清、王毅飞、孙金妮 （2）董事会提名委员会 果德安（主任委员）、文光伟、程翔林、程杰、王毅飞 （3）董事会审计委员会 文光伟（主 ...

Group 1: Development Goals and Framework - The State-owned Assets Supervision and Administration Commission (SASAC) has set the annual development goals centered on "two guarantees and two strives" for 2026, marking a shift towards quality and efficiency in state-owned enterprises (SOEs) [4] - The total assets of central enterprises have surpassed 95 trillion yuan, with R&D investment exceeding 1 trillion yuan for four consecutive years, indicating a focus on quality-driven growth [8] - The framework aims to guide state capital towards strategic security, public welfare, and emerging industries, providing a clear action plan for reform and development [4] Group 2: Industry Integration and Collaboration - In 2025, the restructuring of central enterprises will follow a dual-track approach, focusing on strategic formation of new central enterprises and multi-field professional integration [13] - The establishment of new central enterprises, such as China Yajiang Group and China Chang'an Automobile Group, aims to serve national macro strategies and enhance industry collaboration [14] - A total of 17 units signed agreements in key areas like artificial intelligence and new materials, creating a multi-party collaborative model involving central enterprises, private enterprises, and local governments [16] Group 3: Capital Investment and Fund Management - The total scale of the China Chengtong fund system reached 710 billion yuan, with 97.99% allocated to strategic emerging industries, demonstrating a strong focus on high-tech sectors [18] - The National Investment Group manages 61 funds with a total scale of 345.1 billion yuan, having invested in 1,249 projects and facilitated 293 companies going public [20] - The investment strategy emphasizes long-term support for innovative enterprises, with over two-thirds of funds directed towards private enterprises [20] Group 4: Resource Integration and Security - Central enterprises are undergoing intensive integration in key mineral sectors, such as iron ore and rare earths, to enhance resource control and pricing power [24] - The integration aims to create a closed-loop industry chain, improving domestic supply security and reducing reliance on imports [25] - This strategic move is seen as a vital step in ensuring national resource security and enhancing the global influence of China's mineral resources [24]

Investment Rating - The report maintains a "Buy" rating for key companies in the pharmaceutical sector, including Innovent Biologics, Efang Biologics, Tianshili, WuXi AppTec, and Mindray Medical [4][28]. Core Insights - The policy-driven upgrade of traditional Chinese medicine (TCM) industry is expected to enhance industry concentration in the medium to long term, benefiting companies with strong quality control and innovative capabilities [2][24]. - The implementation plan for high-quality development of the TCM industry aims to establish a collaborative development system by 2030, focusing on raw material supply, innovation, production quality control, and internationalization [2][23]. - The investment strategy emphasizes the importance of clinical value in the pharmaceutical sector, recommending a focus on innovative drugs and high-end medical devices [3][26]. Summary by Sections Market Review - The A-share pharmaceutical index rose by 0.14%, outperforming the CSI 300 index by 1.47 percentage points [1][16]. - The Hong Kong Hang Seng Medical Health Index fell by 1.41%, but still outperformed the Hang Seng Index by 1.65 percentage points [1][16]. Policy Insights - The Ministry of Industry and Information Technology and other departments issued a plan to enhance the TCM industry, which includes fostering leading enterprises and establishing high-standard raw material production bases [2][24]. - The plan emphasizes digitalization and sustainability, aiming to raise compliance standards and accelerate the exit of smaller companies from the market [2][25]. Company Updates - Recent clinical progress includes the NDA submission for HRS-9531 by Heng Rui Medicine and the initiation of clinical trials for various drugs by other companies [1][31][32]. - Key companies such as Yunnan Baiyao, Baiyunshan, and Taiji Group are highlighted for their strong positions in raw material supply [2][25]. Financial Forecasts - The report provides earnings per share (EPS) forecasts for key companies, with Innovent Biologics projected to have an EPS of 0.49 in 2025 and WuXi AppTec expected to reach an EPS of 5.07 in the same year [4][28]. - The pharmaceutical manufacturing industry reported a revenue decline of 1.2% year-on-year for 2025, with total revenue reaching 2,487 billion yuan [51].

Core Viewpoint - The "Global Traditional Chinese Medicine Culture Gala" held in Beijing emphasizes the global recognition and innovative spirit of traditional Chinese medicine (TCM), showcasing its integration with modern technology and health concepts [1][3]. Group 1: Event Overview - The event was co-hosted by Phoenix TV and Dong'e Ejiao, celebrating the ancient wisdom of TCM and its journey onto the global stage [1]. - The gala featured tributes to five individuals who have made significant contributions to the international dissemination and cross-disciplinary integration of TCM [5]. Group 2: Recognition of Contributors - The first honoree, Dr. Ehsan Doustmohammadi from Iran, translated over twenty Chinese classics into Persian, including the "Huangdi Neijing," to enhance understanding of Chinese culture in Iran [5][7]. - The second honoree, Malaysian TCM practitioner Liang Jiarin, innovatively uses space concepts to teach TCM, making it appealing to younger generations [9]. - The third honoree, Dr. Li Zong'en from Silicon Valley, applies AI and big data to systematize TCM practices, aiming to validate traditional knowledge through modern scientific methods [11]. - The fourth honoree, Valeria from Italy, has been practicing TCM for over twenty years, using music to create a calming environment for patients [13]. - The final honoree, Dr. Diallo from Mali, has trained over a thousand local healthcare workers in TCM techniques, serving more than 120,000 patients in Africa [15]. Group 3: Future Initiatives - Following the tribute segment, the second season of "Four Seas TCM" was launched, aiming to document more global TCM stories and foster cross-cultural dialogue [17].

Core Viewpoint - The "Global Traditional Chinese Medicine Culture Festival" successfully showcased the integration of ancient Chinese medicine with modern technology and art, emphasizing its global significance and the need for cultural exchange [1][4]. Group 1: Event Overview - The festival was co-hosted by Phoenix TV and Dong'e Ejiao, held in Beijing, and aimed to present a dialogue between civilizations through the lens of traditional Chinese medicine [1]. - The event took place on the day of the beginning of spring, symbolizing renewal and vitality, and highlighted the confidence and openness of traditional Chinese medicine on the global stage [1]. Group 2: Key Contributions and Honorees - Five individuals were honored for their outstanding contributions to the international dissemination and integration of traditional Chinese medicine [2]. - Eisen Doustmohammadi from Iran was recognized for translating the "Huangdi Neijing" into Persian and building a bridge for modern Silk Road Chinese medicine [2]. - Malaysian practitioner Liang Jiarun was acknowledged for his innovative practices in promoting traditional Chinese medicine to younger audiences [2]. - Dr. Li Zongen from the United States was celebrated for integrating AI and big data with traditional Chinese medicine, aiming to modernize its interpretation [2]. - Valeria, a disciple of Master Wang Juyi in Italy, was awarded for her dedication to practicing and spreading traditional Chinese medicine in Italy [3]. - Dr. Diallo from Mali was recognized for his efforts in training local medical personnel and providing healthcare to over 120,000 patients in Africa [3]. Group 3: Cultural Exchange and Future Initiatives - The festival featured an interactive experience area showcasing traditional Chinese medicine products and practices, enhancing public engagement [4]. - The second season of "Four Seas Traditional Chinese Medicine" was launched, aiming to document the global resonance and growth of traditional Chinese medicine [3][4]. - The event concluded with a children's choir performing a theme song co-created with AI, symbolizing the future of traditional Chinese medicine [4].

Core Viewpoint - The Chinese medicine ETF (560080) has shown positive performance with most constituent stocks rising, indicating a favorable market sentiment towards the Chinese medicine sector [1][6]. Group 1: Stock Performance - Major stocks in the Chinese medicine ETF have seen significant gains, with Da Ren Tang rising over 4%, Pian Zai Huang over 3%, and Tong Ren Tang over 2% [1]. - The estimated weights and performance of key stocks include: - Yunnan Baiyao at 10.56% with a 1.47% increase - Pian Zai Huang at 9.21% with a 3.78% increase - Dong E E Jiao at 6.18% with a 0.73% increase [2]. Group 2: Technological Advancements - The launch of the first "Traditional Chinese Medicine Brain-Machine Interface" equipment marks a significant technological advancement, aimed at treating neurological disorders [3]. - This technology integrates brain-machine interface with acupuncture, showcasing innovation in the field of traditional medicine [3]. Group 3: Policy Developments - The implementation of the "Drug Administration Law Implementation Regulations" emphasizes a review system for traditional Chinese medicine based on traditional theories, human experience, and clinical data [4]. - The regulations aim to ensure the safety and traceability of traditional Chinese medicine products, which may lead to industry consolidation and growth for leading companies [4]. Group 4: Investment Opportunities - Three main investment themes in the Chinese medicine sector are identified: 1. Price governance, focusing on competitive products and companies that can leverage price reductions for volume growth [5]. 2. Consumption recovery, driven by macroeconomic improvement and an aging population, benefiting companies with strong brand and product advantages [7]. 3. State-owned enterprise reform, which may enhance performance through efficiency improvements in state-controlled companies [8]. Group 5: Market Activity - The Chinese medicine ETF (560080) has seen increased trading activity, with a transaction volume nearing 1 billion yuan and significant capital inflow over recent days [6].

Group 1 - The core point of the article highlights the performance of the Belt and Road ETF managed by E Fund, which experienced a decline of 1.95% to 1.709 yuan as of the midday close on February 5, with a trading volume of 4.9066 million yuan [1] - The major holdings of the ETF include companies such as Xiaogoods City, which fell by 0.07%, Goldwind Technology, which dropped by 9.46%, and China Aluminum, which decreased by 6.77% [1] - The ETF's performance benchmark is the CSI State-Owned Enterprises Belt and Road Index, with a return of 74.37% since its inception on November 6, 2019, and a return of 9.89% over the past month [1] Group 2 - The fund is managed by E Fund Management Co., Ltd., with Liu Shurong as the fund manager [1] - The article provides a snapshot of the performance of various stocks within the ETF, indicating mixed results with some stocks like Dong'a Ejiao increasing by 0.20% and others like Nanjing Energy decreasing by 7.89% [1] - The article emphasizes the importance of cautious investment, noting that market risks exist [1]

Group 1: Canned Food Industry - The State Administration for Market Regulation has released draft recommendations for national standards for canned food to enhance industry standards and applicability [3] - The canned food industry in China is diverse but lacks innovation, particularly in attracting younger consumers, with Fujian province accounting for 36% of national production [3][4] - The industry is upgrading through the development of self-heating foods, high-end products like bird's nest canned food, and customized dining products [3][4] Group 2: New Beverage Trends - The sugar water shop has become a new franchise trend, with brands like Mai Ji Milk and Zhao Ji Chuan Cheng rapidly expanding, but facing challenges such as high costs and low-frequency consumption [5] - The Chinese herbal health water market is experiencing a sales surge due to hot weather, with products like red bean and coix seed water gaining popularity, potentially exceeding a market size of 10 billion yuan [6] - The beverage market is accelerating its health trend, with low-sugar and no-sugar products becoming standard, while traditional giants face declining sales [7] Group 3: Functional and Innovative Products - Vitamin drinks are gaining popularity among young consumers for their health benefits, with sales of Nongfu Spring's water-soluble C100 increasing by 34% year-on-year [9] - The rise of banana-flavored drinks from major brands reflects a growing market potential, leveraging high national recognition and health trends [10] - The global nutrition and health industry is set for a peak in raw material innovation and technological iteration by 2025, with a focus on standardized and stable ingredients [11] Group 4: Market Dynamics and Brand Strategies - The "medicinal food" trend is becoming a significant market, with a projected scale of 370 billion yuan, driven by policy support and technological advancements [12] - The rise of Chinese herbal health water reflects a shift in consumer behavior towards health-conscious products, but the industry faces challenges like exaggerated claims and quality control [14] - The dairy industry is shifting focus from consumer markets to B2B markets, driven by the growth of new consumption formats like tea and coffee [15] Group 5: Brand Developments and Challenges - The beverage brand Commune is preparing for an IPO, aiming to expand its presence while facing challenges like declining same-store sales and rising costs [24] - The acquisition of the beverage brand Dayao by KKR marks a shift towards capitalizing on efficiency over emotional branding, as the brand faces challenges in national expansion [25] - Dongpeng's coffee brand has achieved a market share of 14%, positioning itself among the top three in the ready-to-drink coffee market through a focus on quality and targeted marketing [26]

Group 1 - The "Global Traditional Chinese Medicine Culture Festival" will officially open on February 4 at the Beijing Phoenix Center, coinciding with the traditional Chinese solar term "Lichun," symbolizing the revival of life and the integration of traditional Chinese medicine (TCM) into global health narratives [1][2] - The festival is co-hosted by Phoenix TV and Dong'e Ejiao, focusing on the theme "TCM Going Global," aiming to deeply integrate TCM culture with modern technology and art [1][2] - The event will feature three core segments, including interactive experiences, thematic discussions, and a tribute ceremony, showcasing the global presence and cultural vitality of TCM [1][3] Group 2 - Five TCM cultural promoters from around the world will be honored at the festival, including figures from the United States, Malaysia, Iran, Italy, and Mali, each contributing to the promotion and integration of TCM with modern science and culture [3] - The festival has received strong support from various organizations, including the Hong Kong Center for the TCM industry chain, the France-China TCM Center, and the United Nations Global Compact's "Belt and Road" action platform [3] Group 3 - A pre-event live broadcast titled "Chatting with Friends of TCM" will take place on February 4 at 15:30, featuring special guests who will engage in light discussions and answer questions from the audience [4]